Literature DB >> 9708184

Immunization of mice with phosphatidylcholine drastically reduces the parasitaemia of subsequent Plasmodium chabaudi chabaudi blood-stage infections.

G Bordmann1, W Rudin, N Favre.   

Abstract

It has been suggested that phospholipids and antibodies directed against phospholipids are important in the pathology of malaria. We have investigated the influence of immunizations with phospholipids on the course of subsequent blood-stage Plasmodium chabaudi chabaudi infections in ICR inbred mice. We observed a significant reduction in the parasitaemia following immunization with phosphatidylcholine (PC), but not with phosphatidylethanolamine (PE) immunization. At the peak of the infection, PC-immunized mice displayed a T-helper 2 (Th2)-type cytokine production pattern, whereas PE-immunized or non-treated controls displayed a cytokine production pattern of the T-helper 1 (Th1) type. Serum immunoglobulin transfer from PC-immunized mice protected naive mice in a similar fashion to PC-immunization, demonstrating that the observed reduction of parasitaemia was caused by the presence of PC-specific antibodies.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9708184      PMCID: PMC1364328          DOI: 10.1046/j.1365-2567.1998.00479.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  18 in total

1.  Comparison of cytokine measurements using ELISA, ELISPOT and semi-quantitative RT-PCR.

Authors:  N Favre; G Bordmann; W Rudin
Journal:  J Immunol Methods       Date:  1997-05-12       Impact factor: 2.303

2.  Ig-isotype patterns of primary and secondary B cell responses to Plasmodium chabaudi chabaudi correlate with IFN-gamma and IL-4 cytokine production with CD45RB expression by CD4+ spleen cells.

Authors:  M R D'Império Lima; J M Alvarez; G C Furtado; T L Kipnis; A Coutinho; P Minóprio
Journal:  Scand J Immunol       Date:  1996-03       Impact factor: 3.487

3.  High levels of anti-phospholipid antibodies in uncomplicated and severe Plasmodium falciparum and in P. vivax malaria.

Authors:  C A Facer; G Agiostratidou
Journal:  Clin Exp Immunol       Date:  1994-02       Impact factor: 4.330

4.  Tumour necrosis factor induction by malaria exoantigens depends upon phospholipid.

Authors:  C A Bate; J Taverne; E Román; C Moreno; J H Playfair
Journal:  Immunology       Date:  1992-01       Impact factor: 7.397

Review 5.  The roles of cytokines produced in the immune response to the erythrocytic stages of mouse malarias.

Authors:  T von der Weid; J Langhorne
Journal:  Immunobiology       Date:  1993-11       Impact factor: 3.144

Review 6.  Neutralizing monoclonal antibodies to glycosylphosphatidylinositol, the dominant TNF-alpha-inducing toxin of Plasmodium falciparum: prospects for the immunotherapy of severe malaria.

Authors:  L Schofield; L Vivas; F Hackett; P Gerold; R T Schwarz; S Tachado
Journal:  Ann Trop Med Parasitol       Date:  1993-12

7.  Stimulators of tumour necrosis factor production released by damaged erythrocytes.

Authors:  C A Bate; D P Kwiatkowski
Journal:  Immunology       Date:  1994-10       Impact factor: 7.397

8.  A prognostic role for anti-phosphatidyl choline antibodies in human cerebral malaria.

Authors:  B K Das; S Parida; B Ravindran
Journal:  Clin Exp Immunol       Date:  1996-03       Impact factor: 4.330

9.  Phospholipids coupled to a carrier induce IgG antibody that blocks tumour necrosis factor induction by toxic malaria antigens.

Authors:  C A Bate; J Taverne; D Kwiatkowski; J H Playfair
Journal:  Immunology       Date:  1993-05       Impact factor: 7.397

10.  Signal transduction in host cells by a glycosylphosphatidylinositol toxin of malaria parasites.

Authors:  L Schofield; F Hackett
Journal:  J Exp Med       Date:  1993-01-01       Impact factor: 14.307

View more
  4 in total

1.  19 A solution structure of the filarial nematode immunomodulatory protein, ES-62.

Authors:  Claire J Ackerman; Margaret M Harnett; William Harnett; Sharon M Kelly; Dmitri I Svergun; Olwyn Byron
Journal:  Biophys J       Date:  2003-01       Impact factor: 4.033

2.  High prevalence of co-factor independent anticardiolipin antibodies in malaria exposed individuals.

Authors:  P H Consigny; B Cauquelin; P Agnamey; E Comby; P Brasseur; J J Ballet; C Roussilhon
Journal:  Clin Exp Immunol       Date:  2002-01       Impact factor: 4.330

Review 3.  Combating malaria with nanotechnology-based targeted and combinatorial drug delivery strategies.

Authors:  Miloni Thakkar; Brijesh S
Journal:  Drug Deliv Transl Res       Date:  2016-08       Impact factor: 4.617

Review 4.  Current Understanding of Natural Antibodies and Exploring the Possibilities of Modulation Using Veterinary Models. A Review.

Authors:  G IJsbrand Reyneveld; Huub F J Savelkoul; Henk K Parmentier
Journal:  Front Immunol       Date:  2020-09-10       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.